States have largely dismissed weakening policies, but legislatures are likely to continue considering vaccine-related bills, which may allow public health leaders to work collaboratively toward ...
In anticipation of the upcoming presidential election in November, the Republican and Democratic National Committees released their platforms. These platforms provide an overview of values, policies, ...
Many pharmaceutical companies urgently began developing a COVID-19 vaccine earlier this year to reduce the spread of the virus as the threat of a pandemic loomed. Fast forward several months and ...
As public health officials lead the pandemic response, clear direction-setting in every state and territories is vital to assure our planning and implementation is fair and focused on those most at ...
If there is any word to describe 2020 it is “unprecedented,” with the work of health agencies front and center since COVID-19 emerged in the U.S. But as we approach Public Health Thank You Day and ...
With many of the state and territorial legislatures reconvening over the next few weeks, we can look forward to new (and not-so-new) legislation start to crop up that will impact public health. To ...
Anticipating a rapid deployment of COVID-19 vaccines as they are authorized, the CDC developed COVID-19 Vaccination Program Operational Guidance in collaboration with state and local jurisdictions to ...
Each year the U.S. battles seasonal influenza, leaving millions of people sick, hospitalized, or worse. As COVID-19 cases continue to rise, it is crucial for all eligible individuals to receive a flu ...
Pharmacies have long been instrumental partners in providing lifesaving vaccines nationwide. As state and territorial health officials evaluate their COVID-19 response, planners must include input ...
Vaccines are one of the greatest public health achievements of the last century, as well as some of the most powerful and cost-effective tools to prevent disease, disparities, disability, and death ...
Public health officials from all levels of government are working to respond to the existing outbreak of monkeypox, while preparing for the potential of more widespread transmission.
On Aug. 23, 2021, the FDA announced full approval of Pfizer and BioNTech’s mRNA vaccine for COVID-19. ASTHO has answers to five key questions about the approval and what it means for state and ...
The COVID-19 pandemic provided an unprecedented opportunity to speed up developing Delaware’s Functional Assessment Service Team and to test it at scale.
A discussion with Meredith Allen, ASTHO’s Vice President for Health Security, about how the first shipments of the COVID-19 vaccinations have been a major turning point for the pandemic and a ...
On Aug. 11, 2021, CDC updated its guidance on COVID-19 vaccination for pregnant or breastfeeding individuals. We’ve answered seven common questions about the new guidance and what it means for state ...
As the number of COVID-19 vaccinations grows, some states are looking at their vaccination rates to determine when to loosen measures that mitigate the spread of COVID-19, such as venue capacity ...
This week might have marked the beginning of summer, but many policymakers and health officials have their eye on the upcoming school year and what that might mean in terms of getting students ...
As the COVID-19 Delta variant surges across the country, public and private employers have started instituting COVID-19 vaccination, testing, and masking protocols for their employees. On July 29, ...
Increasing and maintaining vaccine coverage is an important way to prevent the spread of disease and keep communities healthy. This post is an overview of 2019 state vaccine legislative activities.
In commemoration of National Influenza Vaccination Week ASTHO is highlighting work in Arkansas and South Carolina, where unique collaborations with healthcare and public health have allowed them to ...